Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia
A phase 2 trial of Fostamatinib and Ruxolitinib in Primary myelofibrosis, run by Washington University School of Medicine, recorded as terminated on the registry.
Overview
Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia is a phase 2 interventional study registered as NCT04543279 by Washington University School of Medicine, with 3 participants recorded, started 2021-05-03 and due to reach its primary completion in 2022-07-01. Interventions recorded: Fostamatinib, Ruxolitinib. Conditions recorded: Myelofibrosis, Thrombocytopenia.
Linked to the drug Fostamatinib because the registry names it among its interventions and Primary myelofibrosis among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialStudy to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer
Shares Fostamatinib and the tag pipeline.
- TrialA Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H..
Shares Fostamatinib and the tag pipeline.
- TrialA Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)
Shares Ruxolitinib, Primary myelofibrosis and the tag pipeline.
- TrialStudy of Selinexor in Combination With Ruxolitinib in Myelofibrosis
Shares Ruxolitinib, Primary myelofibrosis and the tag pipeline.
- TrialExtended Access of Momelotinib in Adults With Myelofibrosis
Shares Primary myelofibrosis and the tag pipeline.
- TreatmentNavitoclax
Shares Primary myelofibrosis and the tag pipeline.
- TrialKRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera
Shares Ruxolitinib and the tag pipeline.
- TrialRollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)
Shares Ruxolitinib and the tag pipeline.